| 英文名称 |
中文名称 |
CAS |
|
|
|
309726-06-5 |
|
SARS-CoV-2-IN-41
|
|
2920904-06-7 |
|
AlMotriptan N-Oxide Hydrochloride Salt
|
|
603137-43-5 |
|
|
|
76896-80-5 |
|
Epetraborole hydrochloride
|
|
1234563-16-6 |
|
Acerogenin G
|
|
130233-83-9 |
|
CC-115 hydrochloride
|
|
1300118-55-1 |
|
TVB-2640
|
|
1399177-37-7 |
|
BTSA1
|
|
314761-14-3 |
|
N-{3-[(2-{[3-Fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}acrylamide (2Z)-2-butenedioate hydrate (1:1:2)
|
|
1822357-78-7 |
|
ADU-S100
|
|
1638750-95-4 |
|
MAC glucuronide linker-1
|
|
2222981-71-5 |
|
Autogramin-1
|
|
2375541-73-2 |
|
Sultosilic acid, piperazine salt
|
|
57775-27-6 |
|
VX-548 intermediate
|
|
2649469-37-2 |
|
|
|
3011930-28-9 |
|
BMS-986308
|
|
2254333-97-4 |
|
|
|
2925030-26-6 |
|
1-Methyl-azetidin-3-one
|
|
1144032-03-0 |
|
UK 383367
|
|
348622-88-8 |
|
7-Hydroxy-2-oxo-2H-chromene-3-carbaldehyde
|
|
277313-50-5 |
|
|
|
2079068-74-7 |
|
Actinium-225-PSMA-Trillium(BAY3563254)
|
|
1702967-37-0 |
|
Uricosuricagent-1
|
|
91627-33-7 |
|
Sulfacytine
|
|
17784-12-2 |
|
|
|
1344469-28-8 |
|
Indazole-Cl
|
|
848142-62-1 |
|
SPD-473 citrate
|
|
161190-26-7 |
|
Mal-amido-PEG2-Val-Cit-PAB-PNP
|
|
2112738-13-1 |
|
TCMDC-135051
|
|
2413716-15-9 |
|
CAM 833
|
|
2758364-02-0 |
|
|
|
306296-47-9 |
|
|
|
2790481-63-7 |
|
|
|
4416-57-3 |
|
|
|
2921711-74-0 |
|
(S)-1-(5-Fluoro-pyrimidin-2-yl)-ethylamine hydrochloride
|
|
935667-21-3 |
|
BMN 673
|
|
1207454-56-5 |
|
Silvestrol aglycone
|
|
960365-65-5 |
|
ADU-S100 ammonium salt
|
|
1638750-96-5 |
|
Citric anhydride
|
|
24555-16-6 |
|
ASN007
|
|
2055597-12-9 |
|
VU6028418
|
|
2649803-05-2 |
|
TNIK inhibitor OBD9
|
|
2099064-75-0 |
|
FAZ-3532
|
|
3036029-72-5 |
|
Seletracetam
|
|
357336-74-4 |
|
(S)-batylalcohol
|
|
6129-13-1 |
|
Heptaminol
|
|
372-66-7 |
|
tris-NTA Trifluoroacetic Acid Salt
|
|
862778-60-7 |
|
Mal-PEG5-PFP ester
|
|
1415800-42-8 |
|
Solriamfetol hydrochloride
|
|
178429-65-7 |
|
Maleimide-PEG2-CH2CH2PFP Ester
|
|
1347750-81-5 |
|
BPO-27 racemat
|
|
1314873-02-3 |
|
SJF-8240
|
|
2230821-68-6 |
|
2,4-dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol
|
|
2974417-82-6 |
|
BIIB-014, CEB-4520
|
|
442908-10-3 |
|
Rob 803
|
|
872178-65-9 |
|
NVP-BGJ398 phosphate
|
|
1310746-10-1 |
|
(S)-Pomalidomide
|
|
202271-89-4 |
|
Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-
|
|
80305-11-9 |
|
ATR-IN-4
|
|
2574545-45-0 |
|
SARM1-IN-2
|
|
2396592-52-0 |
|
Idraparinux
|
|
149920-56-9 |
|
|
|
28822-58-4 |
|
Lubabegron fumarate
|
|
391920-32-4 |
|
Afegostat tartrate/AT 2101/D-Isofagomine tartrate/Isofagomine tartrate
|
|
919364-56-0 |
|
|
|
1383376-92-8 |
|
ASP8302
|
|
1839583-42-4 |
|
ML141
|
|
71203-35-5 |
|
SU14813
|
|
452105-23-6 |
|
PSI-7409 tetrasodium
|
|
1621884-22-7 |
|
Methyl (S)-3-bromo-2-methylpropanoate
|
|
98190-85-3 |
|
Vabicaserin hydrochloride
|
|
887258-94-8 |
|
MRT199665
|
|
1456858-57-3 |
|
Aspacytarabine
|
|
2098942-53-9 |
|
(4-NH2)-Exatecan
|
|
2495742-21-5 |
|
|
|
185243-69-0 |
|
DCZ5418
|
|
2883709-99-5 |
|
Kojibiose
|
|
2140-29-6 |
|
Tienilic Acid
|
|
40180-04-9 |
|
Emprumapimod
|
|
765914-60-1 |
|
Imidodicarbonic acid, 2-[[[(1,1-dimethylethoxy)carbonyl]imino][[(1,1-dimethylethoxy)carbonyl][[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]amino]methyl]-, 1,3-bis(1,1-dimethylethyl) ester
|
|
1628040-59-4 |
|
2-undec-10-enylisothiouronium iodide
|
|
22584-04-9 |
|
|
|
2237268-90-3 |
|
Platelet Activating Factor-16
|
|
74389-68-7 |
|
CASIN
|
|
425399-05-9 |
|
Edoxaban Impurity 28（M6）
|
|
480449-52-3 |
|
|
|
136152-65-3 |
|
Selgantolimod
|
|
2004677-13-6 |
|
|
|
494844-07-4 |
|
STF-1623
|
|
|
|
|
|
2930690-12-1 |
|
F-14512 (free base)
|
|
866874-63-7 |
|
CGP 20712 A
|
|
105737-62-0 |
|
|
|
2624313-16-0 |
|
|
|
2400937-45-1 |
|
(R)-5-((R)-2-Bromo-1-hydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one
|
|
62983-44-2 |
|
|
|
864074-65-7 |
|
Naveglitazar
|
|
476436-68-7 |
|
2-(3-methoxy-2,6-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
|
3012641-61-8 |
|
potassium 4-aminosalicylate
|
|
133-09-5 |
